Empress Medical

Company Overview

Snapshot

Founded in April 2019, Empress Medical operates with 1–10 employees. The company has secured funding across one round from one investor, Med Venture Holdings, to advance its fibroid treatment solutions.

Business overview

Empress Medical is dedicated to transforming the standard of care for women globally by developing innovative fibroid treatment solutions. The company's core technology involves an easy-to-use laparoscopic system designed for gynecologists, aiming to reduce hysterectomies and preserve fertility. The Empress system treats symptomatic uterine fibroids by inducing fibroid tissue ischemia through sutures wrapped around the fibroid, leading to necrosis of the fibroid tissue. Empress Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving both consumers and healthcare providers.

Company Intelligence Q&A

What is Empress Medical's primary focus?

Empress Medical is focused on developing fibroid treatment solutions to change the standard of care for women worldwide and reduce the number of hysterectomies.

What technology does Empress Medical utilize?

Empress Medical utilizes an easy-to-use laparoscopic technology designed for gynecologists to provide a uterus-preserving fibroid treatment option.

How does the Empress system treat uterine fibroids?

The Empress system treats symptomatic uterine fibroids in a laparoscopic procedure by inducing fibroid tissue ischemia, where sutures wrapped around the fibroid increase intra-tumoral pressure, leading to blockage of blood flow and eventual necrosis of the fibroid tissue.

When was Empress Medical founded?

Empress Medical was founded in April 2019.